St. Francis Cancer Center | St. Francis Cancer Center | MK-3475-170
st francis cancer center, cancer center greenville sc, cancer care greenville sc, aya cancer care, aya cancer care greenville sc
1420
clinical-trial-template-default,single,single-clinical-trial,postid-1420,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-3.7,wpb-js-composer js-comp-ver-4.12,vc_responsive

Clinical Trials

MK-3475-170

A Phase II Study of Pembrolizumab (MK-3475) in Subjects with Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma (rrPMBCL).  Read More >

« Available Clinical Trials